{"id":37710,"date":"2017-01-09T08:06:55","date_gmt":"2017-01-09T13:06:55","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37710"},"modified":"2017-01-09T08:06:55","modified_gmt":"2017-01-09T13:06:55","slug":"novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710","title":{"rendered":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Novavax, Inc. (NASDAQ:NVAX)<\/strong> recently reported about its Q4 2016 in September 2016. The company\u2019s EPS or earnings per share, stood at $-0.24\/Share. The collective analysts\u2019 estimate was $-0.26\/Share, which means that the $0.02 difference was found.<\/p>\n<h2 style=\"text-align: justify;\"><strong>Analysts counting on Novavax, Inc.<\/strong><\/h2>\n<p style=\"text-align: justify;\">According to the analysts, the company\u2019s Revenue Estimates for the present quarter can be as close to $5.45 Million. The high and low forecasts were created at $9 Million &amp; $3.5 Million, respectively. The analysts are giving Novavax, Inc. a prospect to redeem itself, despite a salvaging year throughout. It still has the revenue potential to bounce back.<\/p>\n<p style=\"text-align: justify;\">While several researchers have updated or revised their call for company, the question is, will Novavax, Inc. bounce back in 2017? Is it possible for the company to keep tanking and salvaging?<\/p>\n<h2 style=\"text-align: justify;\"><strong>Healthcare Conference due- What to expect from Novavax, Inc.? <\/strong><\/h2>\n<p style=\"text-align: justify;\">The company is about to present in the JP Morgan Healthcare Conference on 12 January 2017. The investors will closely watch the company since there is a lot mounting on the declarations to be made there.<\/p>\n<p style=\"text-align: justify;\">Novavax, Inc., which specializes in proprietary recombinant nanoparticle vaccines, may have a few announcements to make. The conference will therefore play a vital role. With Pharma and drugmakers trying to pull up their socks in 2017, Novavax, Inc will have to work towards its USP.<\/p>\n<h2 style=\"text-align: justify;\"><strong>Falling shares over 2016- Will 2017 be better?<\/strong><\/h2>\n<p style=\"text-align: justify;\">Until the end of 2016, the company\u2019s shares had been dwindling in the market. In the middle of November 2016, they had fallen over 17%, at some point of time. The company cannot afford a fall of this level in 2017.<\/p>\n<p style=\"text-align: justify;\">With its Matrix-M\u2122 adjuvant technology, the company can provide vaccines for some of the dreaded and chronic conditions. There shall be a close watch on the company as to what lies in the road ahead. Will there be more to 2017? Will the shares bounce back? The answers to the questions lie hidden somewhere in the tunnel that leads to the times to come or company\u2019s strategic proposals for 2017.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novavax, Inc. (NASDAQ:NVAX) recently reported about its Q4 2016 in September 2016. The company\u2019s EPS or earnings per share, stood at $-0.24\/Share. The collective analysts\u2019 [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":37711,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[12184,6461,12183,12185,7142,6460],"stock_ticker":[],"class_list":["post-37710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-analysts-view","tag-nasdaqnvax","tag-novavax-eps","tag-novavax-healthcare-conference","tag-novavax-inc","tag-novavax-inc-nasdaqnvax","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Novavax, Inc. (NASDAQ:NVAX) recently reported about its Q4 2016 in September 2016. The company\u2019s EPS or earnings per share, stood at $-0.24\/Share. The collective analysts\u2019 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-01-09T13:06:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"125\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016\",\"datePublished\":\"2017-01-09T13:06:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\"},\"wordCount\":340,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg\",\"keywords\":[\"analysts\u2019 view\",\"NASDAQ:NVAX\",\"Novavax EPS\",\"Novavax healthcare conference\",\"Novavax Inc.\",\"Novavax Inc. (NASDAQ:NVAX)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\",\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg\",\"datePublished\":\"2017-01-09T13:06:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg\",\"width\":350,\"height\":125,\"caption\":\"Novavax, Inc.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710","og_locale":"en_US","og_type":"article","og_title":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR","og_description":"Novavax, Inc. (NASDAQ:NVAX) recently reported about its Q4 2016 in September 2016. The company\u2019s EPS or earnings per share, stood at $-0.24\/Share. The collective analysts\u2019 [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-01-09T13:06:55+00:00","og_image":[{"width":350,"height":125,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016","datePublished":"2017-01-09T13:06:55+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710"},"wordCount":340,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg","keywords":["analysts\u2019 view","NASDAQ:NVAX","Novavax EPS","Novavax healthcare conference","Novavax Inc.","Novavax Inc. (NASDAQ:NVAX)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710","url":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710","name":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg","datePublished":"2017-01-09T13:06:55+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/01\/Novavax-Inc..jpg","width":350,"height":125,"caption":"Novavax, Inc."},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/novavax-inc-nasdaqnvax-reports-0-24share-eps-in-q42016-37710#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Novavax, Inc. (NASDAQ:NVAX) Reports $-0.24\/Share EPS In Q42016"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37710"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/37711"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37710"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}